A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Clinical trial NCT04685226 · RECRUITING
Trial details
- NCT number
- NCT04685226
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-27
- Primary completion
- 2028-01-25
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.